Concourse Financial Group Securities’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24
| Closed | -$916 | – | 7391 |
|
|
2024
Q4 | $916 | Buy |
24
+2
| +9% | +$76 | ﹤0.01% | 2108 |
|
|
2024
Q3 | $685 | Sell |
22
-3
| -12% | -$93 | ﹤0.01% | 2109 |
|
|
2024
Q2 | $668 | Sell |
25
-2
| -7% | -$53 | ﹤0.01% | 2169 |
|
|
2024
Q1 | $920 | Buy |
27
+16
| +145% | +$545 | ﹤0.01% | 2146 |
|
|
2023
Q4 | $318 | Sell |
11
-5
| -31% | -$145 | ﹤0.01% | 2219 |
|
|
2023
Q3 | $441 | Sell |
16
-12
| -43% | -$331 | ﹤0.01% | 2196 |
|
|
2023
Q2 | $841 | Sell |
28
-3
| -10% | -$90 | ﹤0.01% | 2157 |
|
|
2023
Q1 | $1.12K | Hold |
31
| – | – | ﹤0.01% | 2146 |
|
|
2022
Q4 | $1.11K | Buy |
31
+2
| +7% | +$71 | ﹤0.01% | 2150 |
|
|
2022
Q3 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 1928 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6869 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6738 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6653 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6446 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6218 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6004 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5817 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5600 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5460 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5408 |
|
|
2019
Q4 | – | Sell |
-52
| Closed | -$1K | – | 5327 |
|
|
2019
Q3 | $1K | Sell |
52
-28
| -35% | -$538 | ﹤0.01% | 1690 |
|
|
2019
Q2 | $3K | Sell |
80
-17
| -18% | -$638 | ﹤0.01% | 1922 |
|
|
2019
Q1 | $3K | Sell |
97
-19
| -16% | -$588 | ﹤0.01% | 1947 |
|
|
2018
Q4 | $3K | Buy |
116
+40
| +53% | +$1.03K | ﹤0.01% | 1851 |
|
|
2018
Q3 | $4K | Buy |
+76
| New | +$4K | ﹤0.01% | 1475 |
|